Description

2-(1,3-Benzoxazol-2-Ylamino)-n-(2-Methoxyphenyl)-4-Methylpyrimidine-5-Carboxamide is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in research and development pipelines. It is primarily sought by pharmaceutical manufacturers and research institutions engaged in developing new therapeutic agents, especially in areas requiring sophisticated molecular scaffolds.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of novel drug candidates, particularly for targeted therapies.
• Research & Development (R&D): Used in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization.
• Active Pharmaceutical Ingredient (API) Synthesis: Incorporated into the final chemical structure of investigational new drugs.
• Biochemical Research: Employed as a tool compound or ligand in biochemical assays and target validation studies.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects.
• Academic Research: Utilized in university and institutional labs for advanced organic synthesis and pharmacological research.

Basic Information

Product Name	2-(1,3-Benzoxazol-2-Ylamino)-n-(2-Methoxyphenyl)-4-Methylpyrimidine-5-Carboxamide
CAS No.	689747-11-3
Molecular Formula	C20H17N5O3
Molecular Weight	375.38 g/mol
Synonyms	2-[(1,3-Benzoxazol-2-yl)amino]-N-(2-methoxyphenyl)-4-methylpyrimidine-5-carboxamide; 2-(Benzoxazol-2-ylamino)-N-(2-methoxyphenyl)-4-methylpyrimidine-5-carboxamide; 4-Methyl-2-[(2-benzoxazolyl)amino]-N-(2-methoxyphenyl)-5-pyrimidinecarboxamide; 689747-11-3; UNII-8X5F4F9Q8K; 8X5F4F9Q8K; SCHEMBL218024; BDBM50389379; AKOS025310923; AS-75911
EINECS	Contact for details

Quality Control

Every batch of 2-(1,3-Benzoxazol-2-Ylamino)-n-(2-Methoxyphenyl)-4-Methylpyrimidine-5-Carboxamide undergoes rigorous analytical testing to ensure it meets the stringent purity requirements for pharmaceutical R&D and manufacturing. Our quality assurance protocols are designed to guarantee batch-to-batch consistency and traceability. A comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles is provided with each shipment to support your quality and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.